BSE · BIBCL
Bharat Immunologicals & Biologicals
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,571
of 5,004 stocks
▼ 2851W
Peak #3,286 · 21 Sep 2026
Bharat Immunologicals & Biologicals is a microcap company in the Healthcare space and is seeing revenue contract sharply, has a subdued return on equity, and has promoters holding 59%.
Market Cap
39.12 Cr
P/E Ratio
—
P/B Ratio
0.44
ROE
-18.86%
ROCE
-16.18%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q3 2022-23 | Q2 2022-23 | Q3 2021-22 | Q2 2021-22 |
|---|---|---|---|---|
| Revenue | Rs 0 | 26.48 Cr | 17.43 Cr | 24.70 Cr |
| Net Profit | -4.68 Cr | -3.08 Cr | -65.94 L | -9.36 Cr |
| EPS | -1.08 | -0.71 | -0.08 | -2.17 |
| Operating Profit | -4.66 Cr | -2.22 Cr | 76.87 L | -3.33 Cr |
Shareholding pattern
Promoter
59.25%
Public
40.75%
PUBLIC BREAKDOWN
Individuals
39.98%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 04 Sep 2002 | Dividend | NIL Dividend - Rs. - 0.0000 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.